Our Business

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and Phosphagenics' ADR's (PPGNY) are traded on the OTCQX in the US.

Breaking News

15 February 2012

PHOSPHAGENICS DELIVERS FURTHER POSITIVE OXYCODONE PATCH TRIAL RESULTS

•   Latest trial demonstrates excellent patch characteristics
•   Development of viable commercial product
•   4.5 x more oxycodone delivered

Phosphagenics today announced positive results from the clinical trial using its new TPM/oxycodone patch.

Phosphagenics Limited Research Reports - RBS Morgans, Bell Potter Report, CCZ Equities Research

Click here for Dr Esra Ogru's Sky News feature (11 Jan 2012)

14 December 2011

PHOSPHAGENICS DECEMBER 2011 E-NEWSLETTER AND PLACEMENT OF SHARES

• December 2011 eNewsletter
• Equity Raising

Phosphagenics Limited is pleased to announce that following the approval granted by shareholders at the General Meeting held on 9 December 2011 the Company advises that it has now issued the 50 million new shares at $0.14 a share. ASX Equity Raising correction.

Phosphagenics Limited Media Coverage December 2011

Read our latest news: December 2011 NEWSLETTER

To view all releases in full please click here